Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$3.26 - $7.08 $100,981 - $219,310
30,976 Added 70.11%
75,161 $246,000
Q1 2024

May 15, 2024

BUY
$3.54 - $8.35 $156,414 - $368,944
44,185 New
44,185 $324,000
Q3 2022

Nov 14, 2022

SELL
$21.04 - $36.06 $469,128 - $804,029
-22,297 Reduced 3.77%
568,382 $12.7 Million
Q2 2022

Aug 15, 2022

SELL
$17.78 - $42.39 $2.5 Million - $5.95 Million
-140,446 Reduced 19.21%
590,679 $14.6 Million
Q1 2022

May 16, 2022

BUY
$29.67 - $60.28 $930,836 - $1.89 Million
31,373 Added 4.48%
731,125 $28.3 Million
Q4 2021

Feb 11, 2022

BUY
$47.84 - $64.34 $4.27 Million - $5.74 Million
89,212 Added 14.61%
699,752 $40.9 Million
Q3 2021

Nov 15, 2021

BUY
$59.27 - $95.73 $21.3 Million - $34.4 Million
359,535 Added 143.24%
610,540 $36.2 Million
Q2 2021

Aug 16, 2021

BUY
$67.25 - $92.52 $4.74 Million - $6.53 Million
70,557 Added 39.1%
251,005 $21.8 Million
Q1 2021

May 17, 2021

SELL
$72.16 - $117.4 $995,591 - $1.62 Million
-13,797 Reduced 7.1%
180,448 $14.9 Million
Q4 2020

Feb 12, 2021

BUY
$38.09 - $100.95 $7.4 Million - $19.6 Million
194,245 New
194,245 $17.7 Million
Q1 2020

May 14, 2020

SELL
$17.28 - $31.88 $674,023 - $1.24 Million
-39,006 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$13.39 - $20.73 $522,290 - $808,594
39,006 New
39,006 $764,000

Others Institutions Holding FATE

About FATE THERAPEUTICS INC


  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $160M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.